These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1993225)

  • 21. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation.
    Cross NC; Feng L; Chase A; Bungey J; Hughes TP; Goldman JM
    Blood; 1993 Sep; 82(6):1929-36. PubMed ID: 8400243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.
    Sawyers CL; Timson L; Kawasaki ES; Clark SS; Witte ON; Champlin R
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):563-7. PubMed ID: 2405384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of BCR/ABL transcripts after BMT for CML detected by PCR reflects a high risk of relapse.
    Hughes TP; O'Shea P; Morgan G; Martiat P; Goldman JM
    Bone Marrow Transplant; 1991; 7 Suppl 2():23. PubMed ID: 1878700
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukaemia.
    Drobyski WR; Endean DJ; Klein JP; Hessner MJ
    Br J Haematol; 1997 Aug; 98(2):458-66. PubMed ID: 9266951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.
    Bär BM; Schattenberg A; Mensink EJ; Geurts Van Kessel A; Smetsers TF; Knops GH; Linders EH; De Witte T
    J Clin Oncol; 1993 Mar; 11(3):513-9. PubMed ID: 8445426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of graft-versus-host disease on the eradication of minimal residual leukemia detected by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation.
    Arnold R; Janssen JW; Heinze B; Bunjes D; Hertenstein B; Wiesneth M; Kubanek B; Heimpel H; Bartram CR
    Leukemia; 1993 May; 7(5):747-51. PubMed ID: 8483329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. bcr/abl chimeric transcript in patients in remission after marrow transplantation for chronic myeloid leukemia: higher frequency of detection and slower clearance in patients grafted in advanced disease as compared to patients grafted in chronic phase.
    Frassoni F; Martinelli G; Saglio G; Sessarego M; Podestà M; Piaggio G; Farabegoli P; Zaccaria A; Testoni N; Remiddi C
    Bone Marrow Transplant; 1995 Oct; 16(4):595-601. PubMed ID: 8528178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
    Schulze E; Krahl R; Thalmeier K; Helbig W
    Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular quantification of residual disease in chronic myelogenous leukemia after bone marrow transplantation.
    Thompson JD; Brodsky I; Yunis JJ
    Blood; 1992 Mar; 79(6):1629-35. PubMed ID: 1547352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. bcr/abl mRNA detection following bone marrow transplantation for chronic myelogenous leukemia.
    Ely P; Miller WJ
    Transplantation; 1991 Dec; 52(6):1023-8. PubMed ID: 1750065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Schaefer UW
    Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay.
    Preudhomme C; Chams-Eddine L; Roumier C; Duflos-Grardel N; Denis C; Cosson A; Fenaux P
    Leukemia; 1999 May; 13(5):818-23. PubMed ID: 10374889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of mixed chimerism to predict relapse in persistently BCR/ABL positive long survivors after allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Román J; Martín C; Torres A; García A; Andrés P; García MJ; Baiget M
    Leuk Lymphoma; 1998 Feb; 28(5-6):541-50. PubMed ID: 9613984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remission.
    Diekmann L; Beelen DW; Quabeck K; Becher R; Schulte Holthausen H; Bützler R; Schaefer UW; Opalka B
    Acta Haematol; 1994; 92(4):169-75. PubMed ID: 7701913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation.
    Lin F; van Rhee F; Goldman JM; Cross NC
    Blood; 1996 May; 87(10):4473-8. PubMed ID: 8639810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.
    Wells SJ; Phillips CN; Winton EF; Farhi DC
    Am J Clin Pathol; 1996 Jun; 105(6):756-60. PubMed ID: 8659451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.